Personalized briefing
Discovery of the day · Diabetes
The most significant scientific discovery today
Dear Dr.Vijay Viswanathan, this is your personalized scientific intelligence briefing — curated for your work in Diabetes.
Key finding
Medicine · Diabetes & Endocrinology
Discovery of the day
[Correspondence] Treatment duration for romosozumab
A new study published in The Lancet Diabetes & Endocrinology reports that a shortened 3-month course of romosozumab followed by 9 months of denosumab produces bone mineral density (BMD) responses that are statistically non-inferior to the standard 12-month romosozumab regimen. Researchers found that although the BMD gains were smaller with the shorter romosozumab duration, the difference did not compromise therapeutic efficacy. For a clinician managing osteoporosis in patients with diabetes—a population at elevated fracture risk—this finding introduces a potential treatment option that may reduce drug exposure, cost, and monitoring burden without sacrificing clinically meaningful BMD improvements.
Novelty
82%
Rigor
90%
Significance
76%
Validity
92%
Clarity
95%
Advertisement
Source lab and medical equipment directly from China — verified suppliers, no middlemen
ScientificChina connects research institutions and procurement teams with trusted Chinese manufacturers of lab instruments, medical devices, and scientific equipment — at a fraction of Western market prices.
Update your briefing preferences →
Science Briefing is published by Fountain of Science LLC, Miami, FL.
Your briefing is personalized based on your selected fields, keywords, and research interests.
